How can a heavy menstrual bleeding scoring system be utilized in practice?
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262085Keywords:
Scoring system, Practice, Validation, Heavy, Menstrual, BleedingAbstract
Background: The objective of the study was to utilise a scoring system which aims to triage women with heavy menstrual bleeding (HMB) into hysterectomy or conservative options in practice. The design of the study was a retrospective study in a UK single centre.
Methods: A six-factor scoring tool to triage women with HMB was identified based on different published evidence. These factors are the presence of a uterine fibroid, chronic pelvic pain/endometriosis, adenomyosis, patient desire for hysterectomy, large uterine cavity and anaemia needing parental therapy. Each factor scores 1, apart from uterine cavity length which scores 2. Hysterectomy would be advised if the score is ≥3, otherwise conservative options would be indicated. For this tool to be clinically recognised, it needed to be validated retrospectively over one year. In order to validate this scoring tool, 327 women aged 25-54 referred with HMB between January 2021 and December 2021 were identified and reviewed. Data was retrieved from patients` records, then divided by outcome. The score was applied to the collected data, patients followed for two years. Differences and associations between variables were examined. Sensitivity and specificity of the scoring system in triaging women with HMB was measured. The application of the validated scoring tool in practice was considered depending on the validation outcome.
Results: 38/327 (11. 6%) of patients had hysterectomy. There was a significant association between having each factor of the score and hysterectomy and a significant association of having a total score of ≥3 and hysterectomy OR 6.23 (95% CI 4.80 – 7.67). The score has a calculated sensitivity of 0.84 (0.68-0.93), specificity of 0.99 (0.97-0.99) and positive predictive value of 0.91 (0.75-0.98). The strongest predictive factor for hysterectomy was large uterine cavity, followed by woman’s desire for hysterectomy, then adenomyosis (p<0.001). Other demographic and clinical variables did not predict hysterectomy as an outcome with the exception of dysmenorhea which when added to the score, it decreased positive predictive value affecting performance. To apply this validated scoring tool in practice, a prospective feasibility trial needs to be conducted prior to a definitive randomised control trial which is on the way.
Conclusions: To use this scoring tool to triage women with HMB in practice, it needed to be validated. Validation has confirmed that this scoring system has high sensitivity and specificity in predicting outcome. Further evaluation of this validated tool in a randomised clinical feasibility trial prior to the definitive trial is needed so the scoring tool can be utilised in practice.
References
Heavy menstrual bleeding: assessment and management. NICE Guideline, No. 88 London: National Institute for Health and Care Excellence (NICE). 2021. Available at: https://www.nice.org.uk/ guidance/ng88. Accessed on 14 March 2026.
Lui Z, Doan QV. Blumenthal P, Dubois RW. A systematic review evaluating health- related quality of life, work impairment, and health care costs and utilization in abnormal uterine bleeding. Value Health. 2007;10(3):183-94.
Copper K, Breeman S, Scott NW, Scotland G, Clark J, Hawe J, et al. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet. 2019;394(10207):1425-36.
Stevens K.Y.R, Meulenbroeks D, Houterman S, Gijsen T, Weyers S, Schoot BC. Prediction of unsuccessful endometrial ablation: a retrospective study. Gynecol Surg. 2019;16(7).
Gupta J, Daniels J, Middleton L, Pattison HM, Prileszky G, Roberts TC, et al. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial. Health Technol Assess. 2015;19(88):1-118.
Kumar V, Chodankar R, Kumar Gupta J. Endometrial ablation for heavy menstrual bleeding. Women’s Health (Lond). 2016;12(1):45-52.
Matteson KA, Abed H, Wheeler TL, Sung VW, Rahn DD, Schaffer JI, et al. A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding. J Minim Invasive Gynecol. 2012;19(1):13-28.
Al-Inizi S. Why do women with Heavy menstrual bleeding end in hysterectomy? Open Access. 2023;2(1):108.
Kiran A, Geary RS, Gurol- Urganci I, Cromwell DA, Bansi-Matharu L, Shakespeare J, et al. Sociodemographic differences in symptom severity and duration among women referred to secondary care for menorrhagia in England and Wales: a cohort study from the National Heavy Menstrual Bleeding Audit. BMJ Open. 2018;8(2):e018444.
Kirstin R, Davies M, Gerald J, Harkins GJ. Characteristics of patients undergoing hysterectomy for failed endometrial ablation. JSLS. 2013;17(4):503-7.
Negida A, Fahim NK, Negida Y. Sample Size Calculation Guide - Part 4: How to Calculate the Sample Size for a Diagnostic Test Accuracy Study based on Sensitivity, Specificity, and the Area Under the ROC Curve. Adv J Emerg Med. 2019;19;3(3):e33.
Royal College of Obstetricians and Gynaecologists, London School of Hygiene & Tropical Medicine (LSHTM), and Ipsos MORI, National Heavy Menstrual Bleeding Audit: Third Annual Report. London, UK: RCOG Press. 2013. Available at: https://www.hquip.org.uk. Accessed on 14 March 2026.
Wang W, Bourgeois T, Klima J, Berlan ED, Fischer AN, O’Brien SH. Iron deficiency, and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia. 2013;19(2):225-30.
Cohen BJ, Gibor Y. Anaemia and menstrual blood loss. Obstet Gynecol Surv. 1980;35:597-618.
Al-Inizi S. How much cost saving can be achieved by introducing a scoring system to triage women with heavy menstrual bleeding? Int J Clin Stud Med Case Rep. 2023;25(4):2-6.
Husu A L, Bell C, Burkman R, Grow D. Hysterectomy after novasure endometrial ablation failure of a bridge to menopause. Fert Steril. 2007;88(1):S193.
Al-Inizi S, Kaur S, Amr M. Heavy menstrual bleeding: Can a scoring system predict the likelihood of hysterectomy? Med J Obs Gyn. 2023;11(1):1164.
Thomassee M, Curlin H, Yunker A, Anderson TL. Predicting pelvic pain after endometrial ablation: which preoperative patient characteristics are associated? J Minim Invasive Gynecol. 2013;20(5):642-7.
Singh S, Bougie O. HEALTH for heavy menstrual bleeding: real-world implications. Open Access. 2019;394(10207):1390-2.
Wortman M. Late-Onset endometrial ablation failure. Case Rep in Womens Health. 2017;12:15:11-28.
McCausland AM, McCausland VM. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol. 1996;174(6):1786-93.
Singh S, Bougie O. HEALTH for heavy menstrual bleeding: real-world implications. Open Access. 2019;394(10207):1390-2.
Seidman JD, Kjerulff KH. Pathologic findings from Maryland Women`s Health Study: practice patterns in the diagnosis of adenomyosis. Int J Gynecol Pathol. 1996;15(3):217-21.
Mengerink B, Van der Wurff, Haar JF, Van Rooij IA, Pinjnenborg J. Effect of undiagnosed deep adenomyosis after failed Novasure endometrial ablation. J Minim Invasive Gynecol. 2015;22(2):239-44.
Singh K, Bharati G, Prasad D, Kumari S. Role of levonorgestrel releasing intrauterine device in management of heavy menstrual bleeding: a conservative approach. Int J Reprod Contracep Obstet Gynecol. 2017;6(2):1-31.
Shazly SA, Famuyide AO, El-Nashar SA, Breitkopf DM, Hopkins MR, Laughlin-Tommaso S. Intraoperative predictors of long-term outcomes after radiofrequency endometrial ablation. J Minim Invasive Gynecol. 2016;23(4):582-9.
Nelson A, Ritchie J. Severe anemia from heavy menstrual bleeding requires heightened attention. Am J Obstet Gynecol. 2015;213(1):97.e1-6.
Mansour D, Hofmann A, Gemzell-Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron-deficiency anaemia in women with heavy menstrual bleeding. Adv Ther. 2021;38(1):201-25.
Van der Meij E, Emanuel M. Hysterectomy for heavy menstrual bleeding. Women`s Health (Lond). 2016,1;12(1):63-9.
Calaf J, Cancelo MJ, Andeyro M, Jimenez JM, Perello J, Correa M, et al. Development and Psychometric Validation of a Screening Questionnaire to Detect Excessive Menstrual Blood Loss That Interferes in Quality of Life: The SAMANTA Questionnaire. J Womens Health. 2020;29(7):1021-31.
Al Wattar B, Shofield S, Minns V, Khan K. Quality of life measurement tools for heavy menstrual bleeding: A systematic review and critical appraisal. Sex Reprod Healthc. 2025;44:101102.